Abstract
Various physiological and pathological changes are related to the occurrence and development of neurodegenerative diseases. Neuroinflammation is a major trigger and exacerbation of neurodegenerative diseases. One of the main symptoms of neuritis is the activation of microglia. Thus, to alleviate the occurrence of neuroinflammatory diseases, an important method is to inhibit the abnormal activation of microglia. This research evaluated the inhibitory effect of trans-ferulic acid (TJZ-1) and methyl ferulate (TJZ-2), isolated from Zanthoxylum armatum, on neuroinflammation, by establishing the human HMC3 microglial cell neuroinflammation model induced by lipopolysaccharide (LPS). The results showed both compounds significantly inhibited the production and expression of nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta) contents, and increased the level of anti-inflammatory factor beta-endorphin (beta-EP). Furthermore, TJZ-1 and TJZ-2 can inhibit LPS-induced activation of nuclear factor kappa B (NF-kappa B). It was found that of two ferulic acid derivatives, both had anti-neuroinflammatory effects by inhibiting the NF-kappa B signaling pathway and regulating the release of inflammatory mediators, such as NO, TNF-alpha, IL-1 beta, and beta-EP. This is the first report that demonstrates that TJZ-1 and TJZ-2 had inhibitory effects on LPS-induced neuroinflammation in human HMC3 microglial cells, which indicates that two ferulic acid derivates from Z. armatum could be used as potential anti-neuroinflammatory agents.

Keywords Plus:CENTRAL-NERVOUS-SYSTEMOXIDATIVE STRESSINFLAMMATIONNEUROTOXICITYEXPRESSIONAPOPTOSISRAT

Published in MOLECULES,Volume28;10.3390/molecules28052080,MAR 2023